Host Cell Protein Testing: Perspective of Current and Future Techniques

Good Manufacturing Practices (GMP) require that manufacturers demonstrate that they have cleared drug substances of residual HCPs to the lowest level possible prior to releasing their drug products. The methodologies for meeting this challenge are changing rapidly as new instrumentation and techniques are becoming available to laboratories. The following paper outlines the latest developments, focusing on emerging best practices.

"*" indicates required fields

First Name*

Last Name*

Company*

State*